BDBM499427 4-((3-(5-(cyclobutylmethoxy)-3- methylpyridin-2- yl)phenoxy)methyl)-N- (methylsulfonyl)benzamide::US11020381, Example 123

SMILES Cc1cc(OCC2CCC2)cnc1-c1cccc(OCc2ccc(cc2)C(=O)NS(C)(=O)=O)c1

InChI Key InChIKey=HTMIKNCPCKACEY-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 499427   

TargetSodium channel protein type 9 subunit alpha(Human)
Raqualia Pharma

US Patent
LigandPNGBDBM499427(4-((3-(5-(cyclobutylmethoxy)-3- methylpyridin-2- y...)
Affinity DataIC50: 500nMAssay Description:This screen is used to determine the effects of compounds on human Nav1.7 channels, utilizing electrical field stimulation (EFS) system in 96-well pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
US Patent